Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Summers

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Immunopharmacology|April 1, 1992
The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitorR L Bell, P R Young, D Albert, et al.
Shock (Augusta, Ga.)|August 1, 1996
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious ratsD H Albert, G Luo, T J Magoc, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
5-lipoxygenase inhibitory activity of zileutonG W Carter, P R Young, D H Albert, et al.
Journal of Medicinal Chemistry|May 29, 1992
Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonistsD E Guinn, J B Summers, H R Heyman, et al.
Journal of Medicinal Chemistry|March 1, 1990
Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationshipsJ B Summers, K H Kim, H Mazdiyasni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1997
ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway ratsD H Albert, P Tapang, D W Morgan, et al.
Agents and Actions|March 1, 1993
The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitorR L Bell, J Bouska, P R Young, et al.
Journal of Medicinal Chemistry|February 28, 1997
Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitorsT Kolasa, C D Brooks, K E Rodriques, et al.
Journal of Medicinal Chemistry|November 1, 1987
In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenaseJ B Summers, B P Gunn, H Mazdiyasni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 1, 1997
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonistD H Albert, T J Magoc, S D Menacherry, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Immunopharmacology|April 1, 1992
The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitorR L Bell, P R Young, D Albert, et al.
Shock (Augusta, Ga.)|August 1, 1996
ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious ratsD H Albert, G Luo, T J Magoc, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
5-lipoxygenase inhibitory activity of zileutonG W Carter, P R Young, D H Albert, et al.
Journal of Medicinal Chemistry|May 29, 1992
Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonistsD E Guinn, J B Summers, H R Heyman, et al.
Journal of Medicinal Chemistry|March 1, 1990
Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationshipsJ B Summers, K H Kim, H Mazdiyasni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1997
ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in brown Norway ratsD H Albert, P Tapang, D W Morgan, et al.
Agents and Actions|March 1, 1993
The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitorR L Bell, J Bouska, P R Young, et al.
Journal of Medicinal Chemistry|February 28, 1997
Nonsteroidal anti-inflammatory drugs as scaffolds for the design of 5-lipoxygenase inhibitorsT Kolasa, C D Brooks, K E Rodriques, et al.
Journal of Medicinal Chemistry|November 1, 1987
In vivo characterization of hydroxamic acid inhibitors of 5-lipoxygenaseJ B Summers, B P Gunn, H Mazdiyasni, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 1, 1997
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonistD H Albert, T J Magoc, S D Menacherry, et al.
Pageof 4